Cyclophilin A as a Target of Cisplatin Chemosensitizers

顺铂 亲环素 生物 医学 亲环素A 化学 化疗 生物化学 分子生物学 内科学 基因
作者
Gerhard Hamilton
出处
期刊:Current Cancer Drug Targets [Bentham Science Publishers]
卷期号:14 (1): 46-58 被引量:13
标识
DOI:10.2174/15680096113136660109
摘要

Platinum-based chemotherapeutics are the mainstay of treatment of a range of tumors achieving high response rates but limited in the course of disease by appearance of drug resistance. Tumor cells respond with reduced uptake and increased intracellular inactivation of the drugs, as well as increased DNA repair and general resistance to chemotherapyinduced cell death. Cisplatin is known to induce expression of cyclophilins, a group of proteins that have peptidyl-prolyl cis-trans isomerase (PPIase) and molecular chaperone activities, as stress response. Cyclophilin A (CypA) and other members of this family are inhibited by cyclosporin A (CsA) which sensitized diverse drug-resistant tumor cell lines in vitro to cisplatin. This effect of CsA was attributed to metabolic changes, inhibition of DNA repair, enhancement of apoptosis, altered intracellular signal transduction or increased production of reactive oxygen species (ROS), although no definitive explanation was provided so far. Several clinical trials employing cisplatin/carboplatin in combination with CsA yielded unsatisfactory results. Since viral replication was found to be dependent on cyclophilins of the host cells, effective new inhibitors, different from CsA or with low or absent immunosuppressive activity, are in development or clinical trials. Sanglifehrins are more potent than CsA and proved to increase toxicity of cisplatin against hepatocellular cancer cells in vitro. These novel cyclophilin inhibitors may offer new opportunities to achieve reversal of resistance to platinumbased drugs in refractory patients. Responsive cancer patients may be enriched in clinical trials by an identification of the downstream targets of Cyps responsible for chemoresistance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华仔的应助被君子之昔采纳,获得30
1秒前
1秒前
1秒前
Nasser发布了新的文献求助10
1秒前
1秒前
hao完成签到,获得积分10
2秒前
嘻嘻哈哈的应助被愉快翠丝采纳,获得10
2秒前
zhou1216发布了新的文献求助10
2秒前
2秒前
所所的应助被啦啦啦啦啦采纳,获得10
2秒前
04d的应助被任性的芷蕾采纳,获得10
2秒前
2秒前
在看书完成签到,获得积分10
2秒前
宋健发布了新的文献求助10
2秒前
快乐的晟睿完成签到,获得积分10
2秒前
张丁发布了新的文献求助10
3秒前
amity关注了科研通微信公众号
3秒前
Didi关注了科研通微信公众号
3秒前
12345678完成签到,获得积分10
3秒前
Yura发布了新的文献求助30
3秒前
天天快乐的应助被贪玩的丹蝶采纳,获得10
4秒前
1526918042完成签到,获得积分10
4秒前
4秒前
5秒前
头发多多完成签到,获得积分10
5秒前
雨花石完成签到,获得积分10
5秒前
天天向上的应助被Hasson采纳,获得10
5秒前
慕青的应助被伊丽莎白古井采纳,获得10
5秒前
6秒前
cheesy完成签到,获得积分10
7秒前
Ray发布了新的文献求助10
7秒前
小马甲的应助被aaa采纳,获得10
7秒前
7秒前
白苹果完成签到 ,获得积分10
7秒前
7秒前
7秒前
8秒前
帅气的Bond发布了新的文献求助10
8秒前
小汉堡完成签到 ,获得积分10
8秒前
三新荞完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175853
求助须知:如何正确求助?哪些是违规求助? 9567457
关于积分的说明 21792632
捐赠科研通 7770447
什么是DOI,文献DOI怎么找? 3431918
关于科研通互助平台的介绍 2556276
邀请新用户注册赠送积分活动 2477418